Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Fixed Capital/Sales

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
   Fixed Capital/Sales(x) 0.820.890.620.480.45

What is the latest Fixed Capital/Sales ratio of NATH BIOGENES (INDIA) ?

The latest Fixed Capital/Sales ratio of NATH BIOGENES (INDIA) is 0.82 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.82
Mar20230.89
Mar20220.62
Mar20130.48
Mar20120.45

How is Fixed Capital/Sales of NATH BIOGENES (INDIA) Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.82
-7.87
Mar2023 0.89
43.55
Mar2022 0.62
29.17
Mar2013 0.48
6.67
Mar2012 0.45 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Fixed Capital/Sales ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹346.1 Cr 3.8% -5.1% -11.5% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹17,556.0 Cr -1.8% -10% 72% Stock Analytics
KAVERI SEED COMPANY ₹4,564.2 Cr 6.1% 4.7% 42.6% Stock Analytics
VENKYS (INDIA) ₹2,399.5 Cr -1% 0.7% -14.7% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,518.8 Cr -2.3% -10.8% -36.8% Stock Analytics
TIERRA AGROTECH ₹402.6 Cr 2.3% 1.4% -34.8% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

3.8%

-5.1%

-11.5%

SENSEX

3.5%

-0.1%

21.9%


You may also like the below Video Courses